Literature DB >> 2150534

Reference values for ambulatory blood pressure: a meta-analysis.

J Staessen1, R Fagard, P Lijnen, L Thijs, R van Hoof, A Amery.   

Abstract

The aim of the present study was to perform a meta-analysis of published studies in an attempt to determine the mean and range of normal ambulatory blood pressure. Twenty-two studies, including a total of 2638 subjects, were reviewed. Most studies were compatible with a mean 24-h ambulatory pressure in the range of 115/70-120/75 mmHg, a mean daytime pressure of 120/75-125/80 mmHg and a mean night-time pressure of 105/60-110/65 mmHg. With weighting for the number of subjects included in the individual studies, the 24-h ambulatory pressure averaged 117/72 mmHg, the daytime pressure 122/77 mmHg and the night-time pressure 106/64 mmHg. The night:day pressure ratio averaged 0.87 for systolic and 0.83 for diastolic pressure, ranging from 0.79 to 0.92 and from 0.75 to 0.90, respectively, across the individual studies. With the mean +/- 2 standard deviation intervals in the various studies taken as normal, the range of normality averaged 97/57-137/87 mmHg over 24 h, 101/62-143/91 mmHg for the daytime pressure and 86/48-127/79 mmHg for the night-time pressure. Until the results of prospective studies on the relationship between ambulatory blood pressure and the incidence of cardiovascular morbidity and mortality become available, these estimates of normal ambulatory pressure could be applied as reference values in clinical practice.

Mesh:

Year:  1990        PMID: 2150534

Source DB:  PubMed          Journal:  J Hypertens Suppl        ISSN: 0952-1178


  12 in total

Review 1.  Effects of gender on the renin-angiotensin system, blood pressure, and renal function.

Authors:  Amrit K Kang; Judith A Miller
Journal:  Curr Hypertens Rep       Date:  2002-04       Impact factor: 5.369

Review 2.  Noninvasive 24 hour ambulatory blood pressure monitoring: current status.

Authors:  A Stanton; E O'Brien
Journal:  Postgrad Med J       Date:  1993-04       Impact factor: 2.401

3.  Predictive value of ambulatory blood pressure shortly after withdrawal of antihypertensive drugs in primary care patients.

Authors:  F W Beltman; W F Heesen; R H Kok; A J Smit; J F May; P A de Graeff; T K Havinga; F H Schuurman; E van der Veur; K I Lie; B Meyboom-de Jong
Journal:  BMJ       Date:  1996-08-17

4.  Women have significantly greater difference between central and peripheral arterial pressure compared with men: the Bogalusa Heart Study.

Authors:  Rebecca Chester; Gary Sander; Camilo Fernandez; Wei Chen; Gerald Berenson; Thomas Giles
Journal:  J Am Soc Hypertens       Date:  2013-07-12

Review 5.  Modern approaches to blood pressure measurement.

Authors:  J A Staessen; E T O'Brien; L Thijs; R H Fagard
Journal:  Occup Environ Med       Date:  2000-08       Impact factor: 4.402

Review 6.  Hypertension, RAS, and gender: what is the role of aminopeptidases?

Authors:  María Jesús Ramírez-Expósito; José Manuel Martínez-Martos
Journal:  Heart Fail Rev       Date:  2008-01-24       Impact factor: 4.214

Review 7.  Report of the Canadian Hypertension Society Consensus Conference: 2. Diagnosis of hypertension in adults.

Authors:  R B Haynes; Y Lacourcière; S W Rabkin; F H Leenen; A G Logan; N Wright; C E Evans
Journal:  CMAJ       Date:  1993-08-15       Impact factor: 8.262

8.  The Blood Pressure "Uncertainty Range" - a pragmatic approach to overcome current diagnostic uncertainties (II).

Authors:  Cornel Pater
Journal:  Curr Control Trials Cardiovasc Med       Date:  2005-04-06

9.  Pure androgen-secreting adrenal adenoma associated with resistant hypertension.

Authors:  René Rodríguez-Gutiérrez; Mario Arturo Bautista-Medina; Ana Eugenia Teniente-Sanchez; Maria Azucena Zapata-Rivera; Juan Montes-Villarreal
Journal:  Case Rep Endocrinol       Date:  2013-05-29

Review 10.  Should there be sex-specific criteria for the diagnosis and treatment of heart failure?

Authors:  Lawrence E Greiten; Sara J Holditch; Shivaram Poigai Arunachalam; Virginia M Miller
Journal:  J Cardiovasc Transl Res       Date:  2013-11-09       Impact factor: 4.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.